Home page4DX • ASX
add
4DMedical Ltd
Chiusura precedente
4,53Â $
Intervallo giornaliero
4,45Â $ - 5,08Â $
Intervallo annuale
0,23Â $ - 5,08Â $
Cap di mercato
2,72Â Mld AUD
Volume medio
6,19Â Mln
Rapporto P/E
-
Dividendo/Prezzo
-
Borsa valori principale
ASX
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
| (AUD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 1,48Â Mln | -0,12% |
Spese di gestione | 13,34Â Mln | 10,01% |
Utile netto | -5,45Â Mln | 46,48% |
Margine di profitto netto | -368,55 | 46,42% |
Utili per azione | — | — |
EBITDA | -11,80Â Mln | -10,69% |
Aliquota fiscale effettiva | 0,86% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (AUD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 6,88Â Mln | -77,52% |
Totale attivo | 94,81Â Mln | -21,00% |
Totale passivo | 30,58Â Mln | -37,71% |
Patrimonio netto totale | 64,24 Mln | — |
Azioni in circolazione | 493,53 Mln | — |
Prezzo/valore contabile | 32,36 | — |
Redditività dell'attivo | -31,64% | — |
Rendimento sul capitale | -43,76% | — |
Flusso di cassa
Flusso di cassa netto
| (AUD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | -5,45Â Mln | 46,48% |
Liquidità di esercizio | -10,16 Mln | -26,04% |
Contanti da investimenti | -388,44K | -14,42% |
Contanti da finanziamenti | 6,01Â Mln | 2.670,69% |
Flusso di cassa netto | -4,54Â Mln | 47,47% |
Flusso di cassa libero | -5,40Â Mln | -4,62% |
Informazioni
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Fondazione
2013
Sito web
Dipendenti
124